DE69930243D1 - Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu - Google Patents
Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazuInfo
- Publication number
- DE69930243D1 DE69930243D1 DE69930243T DE69930243T DE69930243D1 DE 69930243 D1 DE69930243 D1 DE 69930243D1 DE 69930243 T DE69930243 T DE 69930243T DE 69930243 T DE69930243 T DE 69930243T DE 69930243 D1 DE69930243 D1 DE 69930243D1
- Authority
- DE
- Germany
- Prior art keywords
- vitamin
- iatrogenic
- age
- derivatives
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/061,173 US6051587A (en) | 1998-04-16 | 1998-04-16 | Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
US61173 | 1998-04-16 | ||
PCT/CA1999/000331 WO1999053928A1 (en) | 1998-04-16 | 1999-04-16 | Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69930243D1 true DE69930243D1 (de) | 2006-05-04 |
DE69930243T2 DE69930243T2 (de) | 2006-12-07 |
Family
ID=22034118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69930243T Expired - Fee Related DE69930243T2 (de) | 1998-04-16 | 1999-04-16 | Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu |
Country Status (12)
Country | Link |
---|---|
US (1) | US6051587A (de) |
EP (1) | EP1071430B1 (de) |
JP (1) | JP2002512194A (de) |
AT (1) | ATE319457T1 (de) |
AU (1) | AU765749B2 (de) |
BR (1) | BR9909672A (de) |
CA (1) | CA2328730C (de) |
DE (1) | DE69930243T2 (de) |
ES (1) | ES2260906T3 (de) |
IL (1) | IL139681A0 (de) |
NZ (1) | NZ508142A (de) |
WO (1) | WO1999053928A1 (de) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6716858B1 (en) | 1995-08-28 | 2004-04-06 | Kansas University Medical Center | Methods for inhibiting diabetic complications |
US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
DE60023125T2 (de) | 1999-03-08 | 2006-06-22 | University Of Manitoba, Winnipeg | Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel |
US6489345B1 (en) * | 1999-07-13 | 2002-12-03 | Medicure, Inc. | Treatment of diabetes and related pathologies |
EP1872797A3 (de) * | 1999-08-24 | 2008-04-02 | Medicure International Inc. | Behandlung kardiovaskulärer und verwandter Leiden |
US7442689B2 (en) | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
DE60110054T2 (de) * | 2000-02-29 | 2006-03-09 | Medicure International Inc. | Cardioprotektive phosphonate |
EP1531157B1 (de) * | 2000-02-29 | 2008-03-19 | Medicure International Inc. | Cardioprotektive Phosphonate |
EP1284729A4 (de) * | 2000-04-13 | 2007-12-19 | Mayo Foundation | A-(beta)-42 senkende arzneimittel |
US6897228B2 (en) * | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
WO2002039994A2 (en) | 2000-11-20 | 2002-05-23 | University Of Kansas Medical Center | Methods for the treatment and prevention of urinary stone disease |
US7723327B2 (en) | 2002-07-29 | 2010-05-25 | Cardax Pharmaceuticals, Inc. | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
US20050059659A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for controlling C-reactive protein levels |
US20050004235A1 (en) * | 2002-07-29 | 2005-01-06 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease |
US7763649B2 (en) | 2002-07-29 | 2010-07-27 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for controlling connexin 43 expression |
US7345091B2 (en) * | 2002-07-29 | 2008-03-18 | Cardax Pharmaceuticals, Inc. | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050059635A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling C-reactive protein levels |
US7521584B2 (en) * | 2002-07-29 | 2009-04-21 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of disease |
US20050026874A1 (en) * | 2002-07-29 | 2005-02-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease |
US20050143475A1 (en) * | 2002-07-29 | 2005-06-30 | Lockwood Samuel F. | Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
AU2003256982A1 (en) * | 2002-07-29 | 2004-02-16 | Cardax Pharmaceuticals, Inc. | Structural carotenoid analogs for the inhibition and amelioration of disease |
US7320997B2 (en) * | 2002-07-29 | 2008-01-22 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
US20050148517A1 (en) * | 2002-07-29 | 2005-07-07 | Lockwood Samuel F. | Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
US7375133B2 (en) * | 2002-07-29 | 2008-05-20 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050049248A1 (en) * | 2002-07-29 | 2005-03-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for controlling C-reactive protein levels |
EP1603548A4 (de) * | 2003-02-05 | 2007-10-10 | Myriad Genetics Inc | Verfahren und zusammensetzung zur behandlung neurodegenerativer erkrankungen |
WO2004084895A2 (en) * | 2003-03-27 | 2004-10-07 | Medicure, Inc. | Modulation of cell death |
CA2520422A1 (en) * | 2003-03-27 | 2004-10-07 | Medicure Inc. | Compositions for treating angina |
EP1651195A4 (de) * | 2003-07-11 | 2007-10-03 | Myriad Genetics Inc | Pharmazeutische verfahren, dosierschemata und dosierformen zur behandlung von alzheimerkrankheit |
US20070293538A1 (en) * | 2004-04-13 | 2007-12-20 | Myriad Genetics, Incorporated | Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders |
US20060058269A1 (en) * | 2004-04-14 | 2006-03-16 | Lockwood Samuel F | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
WO2005102356A1 (en) * | 2004-04-14 | 2005-11-03 | Hawaii Biotech, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
EP1745180A1 (de) * | 2004-04-29 | 2007-01-24 | Keystone Retaining Wall Systems, Inc. | Frontverkleidung für stützwände |
EP1773370A1 (de) * | 2004-07-07 | 2007-04-18 | Medicure International Inc. | Kombinationstherapien mit thrombozytenaggregations-arzneimitteln |
US20070060549A1 (en) * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
US20060035864A1 (en) * | 2004-08-10 | 2006-02-16 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
CA2618985A1 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
US20060094749A1 (en) * | 2004-10-28 | 2006-05-04 | Medicure International Inc. | Substituted pyridoxines as anti-platelet agents |
CA2585165A1 (en) * | 2004-10-28 | 2006-05-18 | Medicure International Inc. | Dual antiplatelet/anticoagulant pyridoxine analogs |
US7459468B2 (en) * | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
EP1827455A1 (de) * | 2004-11-26 | 2007-09-05 | Medicure International Inc. | Neue formulierung von pyridoxal 5'-phosphat und herstellungsverfahren |
US7375112B2 (en) * | 2005-01-05 | 2008-05-20 | Medicure International Inc. | Compounds and methods for regulating triglyceride levels |
EP1874289A2 (de) | 2005-03-29 | 2008-01-09 | Cardax Pharmaceuticals, Inc. | Verringerung der komplement-aktivierung und entzündung bei gewebeverletzungen durch carotenoide, carotenoid-analoga oder ihre derivate |
CA2503087A1 (en) * | 2005-03-30 | 2006-09-30 | Medicure International Inc. | Intravenous formulations of pyridoxal 5'-phosphate and method of preparation |
BRPI0613611A2 (pt) * | 2005-07-22 | 2011-01-18 | Myriad Genetics Inc | formulações de alta concentração de fármaco e formas de dosagens |
AU2006317440A1 (en) * | 2005-11-28 | 2007-05-31 | Medicure International Inc. | Selected dosage for the treatment of cardiovascular and related pathologies |
DOP2007000055A (es) | 2006-04-10 | 2007-10-31 | Senosiain S A De C V Lab | Composición farmaceutica que comprende un analgésico y vitaminas |
EP2046119A2 (de) * | 2006-07-07 | 2009-04-15 | Myriad Genetics, Inc. | Behandlung von psychiatrischen störungen |
MX2008003230A (es) * | 2008-03-07 | 2009-09-07 | Senosiain S A De C V Lab | Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b. |
ITMI20121316A1 (it) | 2012-07-27 | 2014-01-28 | Altergon Sa | Complessi di condroitina ad assorbimento transcutaneo |
WO2014063134A1 (en) * | 2012-10-19 | 2014-04-24 | New York University | Methods for inhibiting osteolysis |
RU2629367C1 (ru) * | 2016-11-02 | 2017-08-29 | федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) | Нестероидное противовоспалительное средство на основе напроксена, обладающее низкой гастротоксичностью |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR4492M (de) * | 1965-07-07 | 1966-10-10 | ||
FR6707M (de) * | 1966-04-29 | 1969-02-17 | ||
FR6723M (de) * | 1966-12-30 | 1969-02-17 | ||
FR7503M (de) * | 1967-05-30 | 1969-12-08 | ||
GB1236531A (en) * | 1969-02-12 | 1971-06-23 | Soc D Etudes Prod Chimique | Adenin derivative |
JPS53121765A (en) * | 1977-04-01 | 1978-10-24 | Chugai Pharmaceut Co Ltd | Pyridoxal derivatives |
IL62602A (en) * | 1980-05-19 | 1984-06-29 | Labaz Sanofi Nv | Pyridoxine derivatives,their preparation and pharmaceutical compositions containing them |
US4542026A (en) * | 1983-04-29 | 1985-09-17 | Jose Rios | Method of treating vasomotor disorders |
US4564614A (en) * | 1984-10-11 | 1986-01-14 | Pfizer Inc. | Antiinflammatory methods |
FR2641189B1 (fr) * | 1988-06-20 | 1991-05-10 | Timol Mamoojee | Compositions pharmaceutiques contenant de l'acide acetyl salicylique et de la vitamine b6 |
US20040180865A1 (en) * | 1993-06-04 | 2004-09-16 | Jeffry W. Kreamer | Aspirin and vitamin and/or trace element compositions for the amelioration and treatment of vascular disease |
-
1998
- 1998-04-16 US US09/061,173 patent/US6051587A/en not_active Expired - Fee Related
-
1999
- 1999-04-16 BR BRPI9909672-2A patent/BR9909672A/pt not_active Application Discontinuation
- 1999-04-16 EP EP99915411A patent/EP1071430B1/de not_active Expired - Lifetime
- 1999-04-16 WO PCT/CA1999/000331 patent/WO1999053928A1/en active IP Right Grant
- 1999-04-16 AU AU34029/99A patent/AU765749B2/en not_active Ceased
- 1999-04-16 CA CA002328730A patent/CA2328730C/en not_active Expired - Fee Related
- 1999-04-16 AT AT99915411T patent/ATE319457T1/de not_active IP Right Cessation
- 1999-04-16 DE DE69930243T patent/DE69930243T2/de not_active Expired - Fee Related
- 1999-04-16 ES ES99915411T patent/ES2260906T3/es not_active Expired - Lifetime
- 1999-04-16 JP JP2000544332A patent/JP2002512194A/ja not_active Withdrawn
- 1999-04-16 IL IL13968199A patent/IL139681A0/xx unknown
- 1999-04-16 NZ NZ508142A patent/NZ508142A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL139681A0 (en) | 2002-02-10 |
NZ508142A (en) | 2002-11-26 |
ES2260906T3 (es) | 2006-11-01 |
CA2328730C (en) | 2007-08-21 |
DE69930243T2 (de) | 2006-12-07 |
JP2002512194A (ja) | 2002-04-23 |
BR9909672A (pt) | 2007-07-31 |
WO1999053928A1 (en) | 1999-10-28 |
US6051587A (en) | 2000-04-18 |
CA2328730A1 (en) | 1999-10-28 |
EP1071430B1 (de) | 2006-03-08 |
EP1071430A1 (de) | 2001-01-31 |
AU3402999A (en) | 1999-11-08 |
AU765749B2 (en) | 2003-09-25 |
ATE319457T1 (de) | 2006-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69930243D1 (de) | Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu | |
NO20055880L (no) | Memantin orale doseringsformer | |
BR9709838A (pt) | Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase | |
RU2349336C2 (ru) | Составы для лечения артритных состояний | |
US6485727B1 (en) | Method for treatment of chronic venous insufficiencies using an extract of red vine leaves | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
JP2004516257A (ja) | 糖尿病性神経障害の治療に対する組成物及びその方法 | |
AR035946A1 (es) | Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos | |
RU2000114174A (ru) | Применение фосфолипидных комплексов экстрактов из vitis vinifera в качестве противоатеросклеротических агентов | |
RU2701720C1 (ru) | Комбинации пальмитоилэтаноламида для лечения хронической боли | |
WO2005063269A1 (en) | Composition comprising an aqueous extract of red vine leaves and a antithrombotic agent for the treatment of chronic venous insufficiences | |
BRPI0415322A (pt) | composição farmacêutica antiretroviral, processo para a preparação de uma composição farmacêutica antiretroviral, método para reduzir a carga de consumo de pìlulas para um paciente, método para aumentar a meia-vida in vivo de lamivudina e de zidovudina enquanto não afetando a meia-vida de nevirapina | |
JPH01261334A (ja) | アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法 | |
BRPI0106382B8 (de) | ||
RU2180591C2 (ru) | Средство для лечения сексуальных дисфункций у мужчин | |
Hasani et al. | Clinical Trial of Combined Thymus daenensis Celak and Ziziphus Jujube Mill Syrup in Primary Hypertension | |
CA2551043A1 (en) | The use of cystine or cysteine for the prevention and treatment of oxidative stress caused by haemodialysis and of acute or chronic kidney diseases | |
RU2556962C1 (ru) | Способ лечения хронического описторхоза у больных с розацеа | |
DE3866300D1 (de) | Erzeugnisse, enthaltend gallopamil und prazosin. | |
RU2357747C1 (ru) | Способ лечения больных псориатической болезнью | |
RU2391995C1 (ru) | Средство для лечения злокачественных и доброкачественных новообразований различной локализации | |
FontEla | mEdicinAl plAnts: nAtuRAl but not innocuous (part 1) | |
Fitzpatrick | Melatonin in health and disease | |
JP2004075587A (ja) | プロアントシアニジン配合オタネニンジン抽出物製剤 | |
US20040247709A1 (en) | Composition and method for treating upper abdominal pain and cramping |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |